Wilson, DO, Andrew. “PCSK9 Inhibitors, The Most Significant Advance in Lipid Lowering Therapy Since Statins? A Literature Review”. Osteopathic Family Physician 11, no. 4 (July 13, 2019). Accessed July 14, 2020. https://ofpjournal.com/index.php/ofp/article/view/585.